PPARG and hepatocellular adenoma: In hepatocellular adenoma (HCA) and a subset of HCC, the expression and activity of PPARG is significantly increased, affecting metabolic rearrangements and liver tumorigenesis via the transcriptional regulation of hexokinase 2 (HK2) and M2 pyruvate kinase (PKM2) [36,66].